Biotech researchers at the Chinese Academy of Sciences (CAS) say the new method could feed livestock much more efficiently than natural plants, while using a1/1000th as much land as farming.
The U.S. Department of Energy has announced that four additional heat pump manufacturers successfully produced heat pump prototypes as part of the Residential Cold Climate Heat Pump (CCHP) Technology Challenge. Launched in 2021, this initiative brings together public and private sector stakeholders to address technical challenges and market barriers to adopting next-generation cold-climate heat pumps—a key clean energy technology that can potentially save households $500 a year or more on their utility bills while also slashing harmful carbon emissions.
For many years, research has focused on identifying novel therapies that stimulate beta-cell growth and function to restore insulin production in type 1 diabetics. Now, researchers at the Baker Heart and Diabetes Institute in Melbourne have brought us a step closer to making this a reality, regenerating damaged pancreatic cells so they can produce insulin and functionally respond to blood glucose levels. The novel therapeutic approach has the potential to become the first disease-modifying treatment for type 1 diabetes.
Following promising results from this recent trail, the combination of Moderna’s new mRNA-4157 and KEYTRUDA has been granted Breakthrough Therapy Designation by the FDA in the U.S., and accepted into the Priority Medicines scheme by the European Medicines Agency, for the treatment of high-risk melanoma.
A new study from Australia’s Murdoch University evaluating the effectiveness of an eight-week program focusing on self-compassion and mindfulness found that it reduced symptoms of post-traumatic stress and improved quality of life and connectivity in parts of the brain that regulate emotions.
A team at the Lawrence Livermore National Laboratory has achieved fusion ignition, producing a net energy gain from a fusion reaction for the first time ever. The feat was hailed as a “moment of history” by physicists and another major breakthrough in the quest for near-limitless clean energy.
The discovery of a new compound that can kill a drug-resistant bacterium that kills thousands worldwide every year could prove to be a turning point in the fight against antibiotic resistance.
Researchers at the Massachusetts Institute of Technology exposed CO2 to catalysts and then electrolysis that turns the gas into a powder called sodium formate, which can be safely stored for decades. The breakthrough follows an almost century-long effort to turn CO2 into a cheap, clean fuel. Researchers have previously turned CO2 into fuels that required too much energy to make or were difficult to store long-term.
New research from Maryland-based Sunstone Therapies found that psilocybin-assisted therapy for cancer patients induced a clinically meaningful improvement in depression symptoms, with 80% of participants demonstrating a sustained response and 50% showing full remission of depression symptoms at week one, which was sustained for eight weeks.
A drug that targets the deadliest form of breast cancer was administered to 16 women in three separate doses in a trial conducted at the Cleveland Clinic with funding from the Pentagon. The trial found that the drug elicits no side effects and triggered an immune response in 75% of patients.
